Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

NCT02303730 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Exenatide
DRUG: insulin glargine

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]